Teladoc Health (TDOC) is back in focus after expanding its virtual urgent care, dermatology, and nutrition services onto Walmart’s Better Care Services platform, giving the telehealth provider access to a broader retail customer base.

At a share price of US$7.05, Teladoc Health has seen recent momentum cool, with a 7 day share price return down 10.87% and a 1 year total shareholder return down 4.73%. However, the 90 day share price return, up 26.57%, suggests sentiment has picked up from earlier lows, even as investors weigh both the Walmart partnership and the ongoing fiduciary duty investigation.

If this kind of retail health partnership catches your interest, it can be useful to see what other virtual care players are doing in AI driven medicine by scanning 38 healthcare AI stocks

With Teladoc Health trading near US$7.05 and sitting at a large intrinsic discount of about 48%, investors may question whether the stock is still being overlooked or if the market is already factoring in its future potential.

Most Popular Narrative: 90% Undervalued

Against a last close of $7.05, the most followed narrative pegs Teladoc Health’s fair value near $7.12, and builds a detailed case around future earnings power and margins.

Teladoc's continued investment in product innovation including enhanced cardiometabolic programs and integrated mental health offerings positions the company to capture growing demand for digital management of chronic diseases and leverage the increasing need for cost-effective care, supporting long-term revenue and enrollment growth.

Want to see what sits behind that growth story and valuation gap? The narrative leans heavily on specific revenue paths, margin shifts and future earnings assumptions.

Result: Fair Value of $7.12 (UNDERVALUED)

However, the narrative could be knocked off course if BetterHelp’s shift toward lower margin insurance revenue drags on profitability or if chronic care competition squeezes pricing and member growth.

Next Steps

With sentiment clearly split between risks and rewards, it makes sense to move quickly, review the data for yourself, and weigh up 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop at Teladoc Health, you could miss other compelling setups, so use this moment to widen your watchlist with data driven stock ideas across the market.

• Jump on potential mispricing by scanning 48 high quality undervalued stocks that combine quality fundamentals with discounted share prices.
• Build a steadier income stream by reviewing 10 dividend fortresses that pair higher yields with a focus on resilience.
• Prioritise resilience and capital preservation by checking 63 resilient stocks with low risk scores designed to keep overall portfolio risk in check.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.